Open Innovvations - AstraZeneca mobilelogo - Open Innovations
AstraZeneca Logo Newsletter Sign Up

192  Proposals Submitted

molecule icon- AstraZeneca

New Molecule Profiling

The objective of this module is to identify novel compounds active in relevant disease biology assays that serve as the foundation for further collaborative work with external investigators. By providing access to sophisticated cheminformatics and screening technologies, we aim to invite partnerships with top global research talent and ultimately advance the discovery of novel therapeutics to improve patient’s lives.

Why Use AstraZeneca’s New Molecule Open Innovation Module?


AstraZeneca offers external investigators an exceptional opportunity to access our modern drug discovery screening programme, representing a broad range of assays spanning therapeutic areas of current scientific interest. As well as making multiple assays available to external investigators, AstraZeneca will provide in-kind evaluation and characterisation of their compound(s) in a manner which ensures structure confidentiality. All generated data and intellectual property rights are retained by the external investigator.

The Open Innovation application enables efficient transfer of information between AstraZeneca and the external investigator to support collaboration. AstraZeneca will negotiate further access to molecules of interest and/or to partner with the external investigator to advance promising discoveries.

Participation Benefits

Find out more about how it works!